Skip to main content
OpenTrials
Completed

NCT Number: NCT04023097

Self-selection Study of the Toothwave Toothbrush

This study objective is to test the Silk'n Toothwave self-selection, by potential end users. Additionally, this study will evaluate if contraindicated subjects will self-exclude from use of the device and the ability to understand accurately the labeling content (box and user manual).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hellman Dermatology clinic

New York, 10019, United States

About this study

The Silk'n Toothwave Device, in its original packaging, along with the user manual will be provided to the patient in a simulated home use environment. The patient labeling will be in the format intended for distribution.

All subjects will sign an informed consent before any study activity. Five (5) potential end users and Additional five (5) contraindicated subjects will be screened for this self-selection study. Subjects will be provided with the device in its original packaging and will be evaluated for their ability to decide if they are eligible or they should self-exclude themselves from use of the device based solely on reading the device labeling (box and user manual).

Once the subjects complete reviewing the labeling materials (box and user manual) they will be requested to perform a labeling comprehension exam for testing the ability to correctly understand the labeling content.

The study will not include treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is male or female equal to or greater than 18 years of age.
  • Subject is a potential candidate for purchasing the Silk'n Toothwave Device.
  • Subject is capable of understanding and is willing to sign informed consent.

Exclusion criteria

  • Current or history of oral cavity cancer or oropharyngeal cancer.
  • Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
  • Pregnant or nursing.
  • Any active condition in the oral cavity at the discretion of the investigator.
  • Any surgery in the oral cavity within 3 months prior to treatment, or before complete healing.

Modified Inclusion Criteria for contraindicated subjects:

  • Subject with or an active implant, such as a pacemaker, incontinence device, insulin pump, etc.
  • Subject is pregnant or nursing (lactating).

Treatment and study plan

Toothwave toothbrush

Device

Subjects get the device's box with the user manual and the device. However, they don't use the device, but only read the user manual and fill questionnaires.

Primary outcomes

  1. Subjects will mention in the post-reading questionnaire if they should use the Toothwave device or not.

    Time frame: 30 minutes

    Post-reading questionnaire includes the question: "are you allowed to use this device?". Based on reading the user manual and box labeling, subjects should answer "yes" or "no" according to their condition.

Sponsors and collaborators

Lead sponsor

Home Skinovations Ltd.

Industry

Registry information

Official study title

Self-selection Study to Confirm the "Toothwave" Labeling and User Manual Are Clear Enough for Contraindicated Users to Self-exclude Themselves From Using the Device

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jul 17, 2019
Registry last updated
Nov 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.